Your browser doesn't support javascript.
loading
Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma.
Untiedt, Sebastian; Rolf, Daniel; Scobioala, Sergiu; Wolters, Heidi; Elsayad, Khaled; Oertel, Michael; Kittel, Christopher; Pascher, Andreas; Rijcken, Emile; Ullerich, Hansjörg; Glasbrenner, Bernhard; Eich, Hans Theodor.
Afiliación
  • Untiedt S; Department of Radiation Oncology, University Hospital Muenster, 48149, Muenster, Germany. sebastian-untiedt@outlook.de.
  • Rolf D; Department of Radiation Oncology, University Hospital Muenster, 48149, Muenster, Germany.
  • Scobioala S; Department of Radiation Oncology, University Hospital Muenster, 48149, Muenster, Germany.
  • Wolters H; Department of Radiation Oncology, University Hospital Muenster, 48149, Muenster, Germany.
  • Elsayad K; Department of Radiation Oncology, University Hospital Muenster, 48149, Muenster, Germany.
  • Oertel M; Department of Radiation Oncology, University Hospital Muenster, 48149, Muenster, Germany.
  • Kittel C; Department of Radiation Oncology, University Hospital Muenster, 48149, Muenster, Germany.
  • Pascher A; Department for General, Visceral and Transplant Surgery, University Hospital Muenster, 48149, Muenster, Germany.
  • Rijcken E; Department for General, Visceral and Transplant Surgery, University Hospital Muenster, 48149, Muenster, Germany.
  • Ullerich H; Department of Medicine B, Gastroenterology, University Hospital Muenster, 48149, Muenster, Germany.
  • Glasbrenner B; Department of Medicine B, Gastroenterology, St. Franziskus-Hospital Muenster, 48145, Muenster, Germany.
  • Eich HT; Department of Radiation Oncology, University Hospital Muenster, 48149, Muenster, Germany.
Strahlenther Onkol ; 199(8): 749-760, 2023 08.
Article en En | MEDLINE | ID: mdl-36862155
ABSTRACT

PURPOSE:

Primary radiochemotherapy (RCT) constitutes the standard of care for early- and advanced-stage anal carcinoma. This retrospective study investigates the impact of dose escalation on colostomy-free survival (CFS), overall survival (OS), locoregional control (LRC), progression-free survival (PFS), and acute and late toxicities in patients with squamous cell anal cancer.

METHODS:

Considered were the outcomes of 87 patients with anal cancer treated with radiation/RCT between May 2004 and January 2020 at our institution. Toxicities were evaluated according to the Common Terminology Criteria for Adverse Events (CTCAE version 5.0).

RESULTS:

The 87 patients received treatment with a median boost of 63 Gy to the primary tumor. With a median follow-up of 32 months, the 3­year CFS, OS, LRC, and PFS were 79.5%, 71.4%, 83.9%, and 78.5%, respectively. Tumor relapse occurred in 13 patients (14.9%). Dose escalation to > 63 Gy (maximum 66.6 Gy) to the primary tumor in 38/87 patients revealed a nonsignificant trend for improved 3­year CFS (82.4% vs. 97%, P = 0.092), a significantly improved CFS for T2/T3 tumors (72.6% vs. 100%, P = 0.008), and a significantly improved 3­year PFS for T1/T2 tumors (76.7% vs. 100%, P = 0.035). While acute toxicities did not differ, dose escalation > 63 Gy led to a higher rate of chronic skin toxicities (43.8% vs. 69%, P = 0.042). Treatment with intensity-modulated radiotherapy (IMRT) showed a significant improvement in 3­year OS (75.4% vs. 53.8%, P = 0.048). In multivariate analysis, significant improvements for T1/T2 tumors (CFS, OS, LRC, PFS), G1/2 tumors (PFS), and IMRT (OS) were shown. The nonsignificant trend for CFS improvement with dose escalation > 63 Gy was also apparent in multivariate analysis (P = 0.067).

CONCLUSION:

Dose escalation > 63 Gy (maximum 66.6 Gy) may improve CFS and PFS for certain subgroups, with a concomitant increase in chronic skin toxicities. Modern IMRT seems to be associated with an improvement in OS.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Ano / Carcinoma de Células Escamosas / Radioterapia de Intensidad Modulada Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Strahlenther Onkol Asunto de la revista: NEOPLASIAS / RADIOTERAPIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Ano / Carcinoma de Células Escamosas / Radioterapia de Intensidad Modulada Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Strahlenther Onkol Asunto de la revista: NEOPLASIAS / RADIOTERAPIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania